These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22468667)

  • 1. The prescribing of buprenorphine by advanced practice addictions nurses.
    Strobbe S; Hobbins D
    J Addict Nurs; 2012 Feb; 23(1):82-3. PubMed ID: 22468667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine prescribing by APRNs.
    Rundio A
    J Addict Nurs; 2012 Feb; 23(1):80-1. PubMed ID: 22468666
    [No Abstract]   [Full Text] [Related]  

  • 3. Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence.
    Kissin W; McLeod C; Sonnefeld J; Stanton A
    J Addict Dis; 2006; 25(4):91-103. PubMed ID: 17088229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced Practice Nurses: Increasing Access to Opioid Treatment by Expanding the Pool of Qualified Buprenorphine Prescribers.
    Tierney M; Finnell DS; Naegle MA; LaBelle C; Gordon AJ
    Subst Abus; 2015; 36(4):389-92. PubMed ID: 26587696
    [No Abstract]   [Full Text] [Related]  

  • 5. Bupreorphine:a new pharmacotherapy for opioid addictions treatment.
    Stock C; Shum JH
    J Pain Palliat Care Pharmacother; 2004; 18(3):35-54. PubMed ID: 15364630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using buprenorphine to treat patients with opioid use disorder.
    Radi JK; Fogarty KJ; Lagerwey MD
    JAAPA; 2019 Oct; 32(10):30-35. PubMed ID: 31513035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine: effective treatment of opioid addiction starts in the office.
    Fiellin DA
    Am Fam Physician; 2006 May; 73(9):1513-4. PubMed ID: 16719242
    [No Abstract]   [Full Text] [Related]  

  • 8. Nurse Practitioner Prescriptive Authority for Buprenorphine: From DATA 2000 to CARA 2016.
    Fornili KS; Fogger SA
    J Addict Nurs; 2017; 28(1):43-48. PubMed ID: 28252511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rise of buprenorphine prescribing in England: analysis of NHS regional data, 2001-03.
    de Wet CJ; Reed LJ; Bearn J
    Addiction; 2005 Apr; 100(4):495-9. PubMed ID: 15784064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM; McCance-Katz EF
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of NPs in medication-assisted treatment for opioid use disorder.
    Cotton BP; Ferszt GG
    Nurse Pract; 2018 May; 43(5):8. PubMed ID: 29668514
    [No Abstract]   [Full Text] [Related]  

  • 12. Managing opioid addiction with buprenorphine.
    Donaher PA; Welsh C
    Am Fam Physician; 2006 May; 73(9):1573-8. PubMed ID: 16719249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using buprenorphine for outpatient opioid detoxification.
    Manlandro JJ
    J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES11-6. PubMed ID: 17908825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding access to nurse-managed medication for opioid use disorder.
    Cos TA; Starbird LE; Lee H; Chun B; Gonnella K; Bird J; Livsey K; Bastos S; O'Brien M; Clark I; Jenkins D; Tavolaro-Ryley L
    Nurs Outlook; 2021; 69(5):848-855. PubMed ID: 33992445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs approved for opiate dependence.
    FDA Consum; 2003; 37(1):6. PubMed ID: 12625293
    [No Abstract]   [Full Text] [Related]  

  • 16. The disparate treatment of medications and opiate pain medications under the law: permitting the proliferation of opiates and limiting access to treatment.
    Ferrara MM
    Seton Hall Law Rev; 2012; 42(2):741-67. PubMed ID: 22708140
    [No Abstract]   [Full Text] [Related]  

  • 17. Nurse Practitioner and Physician Assistant Waivers to Prescribe Buprenorphine and State Scope of Practice Restrictions.
    Spetz J; Toretsky C; Chapman S; Phoenix B; Tierney M
    JAMA; 2019 Apr; 321(14):1407-1408. PubMed ID: 30964519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Interview With Lisa Clark, MSN.
    Clark L
    J Addict Nurs; 2015; 26(2):106-8. PubMed ID: 26053086
    [No Abstract]   [Full Text] [Related]  

  • 19. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians.
    Arfken CL; Johanson CE; di Menza S; Schuster CR
    J Subst Abuse Treat; 2010 Sep; 39(2):96-104. PubMed ID: 20598829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery Beyond Buprenorphine: Nurse-Led Group Therapy.
    Fogger SA; Lehmann K
    J Addict Nurs; 2017; 28(3):152-156. PubMed ID: 28863059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.